<?xml version="1.0" encoding="UTF-8"?>
<collection xmlns="http://www.loc.gov/MARC21/slim">
 <record>
  <leader>     caa a22        4500</leader>
  <controlfield tag="001">397591608</controlfield>
  <controlfield tag="003">CHVBK</controlfield>
  <controlfield tag="005">20180308164940.0</controlfield>
  <controlfield tag="007">cr unu---uuuuu</controlfield>
  <controlfield tag="008">161202e199610  xx      s     000 0 eng  </controlfield>
  <datafield tag="024" ind1="7" ind2="0">
   <subfield code="a">10.1093/jac/38.4.719</subfield>
   <subfield code="2">doi</subfield>
  </datafield>
  <datafield tag="035" ind1=" " ind2=" ">
   <subfield code="a">(NATIONALLICENCE)oxford-10.1093/jac/38.4.719</subfield>
  </datafield>
  <datafield tag="245" ind1="0" ind2="0">
   <subfield code="a">Kill kinetics of antimicrobial agents against Helicobacter pylori</subfield>
   <subfield code="h">[Elektronische Daten]</subfield>
   <subfield code="c">[R. K. Flamm, J. Beyer, S. K. Tanaka, J. Clement]</subfield>
  </datafield>
  <datafield tag="520" ind1="3" ind2=" ">
   <subfield code="a">We evaluated the activity of clarithromycin, 14-OH clarithromycin, amoxycillin, bismuth, metronidazole and ciprofloxacin against six strains of Helicobacter pylori to determine if there were differences in response to these antimicrobial agents during growth in vitro. Clarithromycin and its 14-hydroxy-metabolite exhibited an early bactericidal activity with at least a 3 log10 reduction after 2-8 h incubation. Exposure to bismuth, ciprofloxacin and metronidazole resulted in a &gt; 3 log reduction by 24 h with the greatest decrease in viability occurring between 8 and 24 h. The viable count of three strains was reduced by a 1-2 log10 after 24 h exposure to amoxycillin and by a &gt; 3 log10 after 48 h.</subfield>
  </datafield>
  <datafield tag="540" ind1=" " ind2=" ">
   <subfield code="a">© 1995 The British Society for Antimicrobial Chemotherapy</subfield>
  </datafield>
  <datafield tag="690" ind1=" " ind2="7">
   <subfield code="a">Brief reports</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Flamm</subfield>
   <subfield code="D">R. K.</subfield>
   <subfield code="u">Abbott Laboratories, Anti-infective Research Division of Pharmaceutical Discovery, D47T-AP3, 100 Abbott Park Road, Abbott Park, IL 60064-3500, USA</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Beyer</subfield>
   <subfield code="D">J.</subfield>
   <subfield code="u">Abbott Laboratories, Anti-infective Research Division of Pharmaceutical Discovery, D47T-AP3, 100 Abbott Park Road, Abbott Park, IL 60064-3500, USA</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Tanaka</subfield>
   <subfield code="D">S. K.</subfield>
   <subfield code="u">Abbott Laboratories, Anti-infective Research Division of Pharmaceutical Discovery, D47T-AP3, 100 Abbott Park Road, Abbott Park, IL 60064-3500, USA</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Clement</subfield>
   <subfield code="D">J.</subfield>
   <subfield code="u">Abbott Laboratories, Anti-infective Research Division of Pharmaceutical Discovery, D47T-AP3, 100 Abbott Park Road, Abbott Park, IL 60064-3500, USA</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="773" ind1="0" ind2=" ">
   <subfield code="t">Journal of Antimicrobial Chemotherapy</subfield>
   <subfield code="d">Oxford University Press</subfield>
   <subfield code="g">38/4(1996-10), 719-725</subfield>
   <subfield code="x">0305-7453</subfield>
   <subfield code="q">38:4&lt;719</subfield>
   <subfield code="1">1996</subfield>
   <subfield code="2">38</subfield>
   <subfield code="o">jac</subfield>
  </datafield>
  <datafield tag="856" ind1="4" ind2="0">
   <subfield code="u">https://doi.org/10.1093/jac/38.4.719</subfield>
   <subfield code="q">text/html</subfield>
   <subfield code="z">Onlinezugriff via DOI</subfield>
  </datafield>
  <datafield tag="908" ind1=" " ind2=" ">
   <subfield code="D">1</subfield>
   <subfield code="a">brief-communication</subfield>
   <subfield code="2">jats</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">856</subfield>
   <subfield code="E">40</subfield>
   <subfield code="u">https://doi.org/10.1093/jac/38.4.719</subfield>
   <subfield code="q">text/html</subfield>
   <subfield code="z">Onlinezugriff via DOI</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Flamm</subfield>
   <subfield code="D">R. K.</subfield>
   <subfield code="u">Abbott Laboratories, Anti-infective Research Division of Pharmaceutical Discovery, D47T-AP3, 100 Abbott Park Road, Abbott Park, IL 60064-3500, USA</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Beyer</subfield>
   <subfield code="D">J.</subfield>
   <subfield code="u">Abbott Laboratories, Anti-infective Research Division of Pharmaceutical Discovery, D47T-AP3, 100 Abbott Park Road, Abbott Park, IL 60064-3500, USA</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Tanaka</subfield>
   <subfield code="D">S. K.</subfield>
   <subfield code="u">Abbott Laboratories, Anti-infective Research Division of Pharmaceutical Discovery, D47T-AP3, 100 Abbott Park Road, Abbott Park, IL 60064-3500, USA</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Clement</subfield>
   <subfield code="D">J.</subfield>
   <subfield code="u">Abbott Laboratories, Anti-infective Research Division of Pharmaceutical Discovery, D47T-AP3, 100 Abbott Park Road, Abbott Park, IL 60064-3500, USA</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">773</subfield>
   <subfield code="E">0-</subfield>
   <subfield code="t">Journal of Antimicrobial Chemotherapy</subfield>
   <subfield code="d">Oxford University Press</subfield>
   <subfield code="g">38/4(1996-10), 719-725</subfield>
   <subfield code="x">0305-7453</subfield>
   <subfield code="q">38:4&lt;719</subfield>
   <subfield code="1">1996</subfield>
   <subfield code="2">38</subfield>
   <subfield code="o">jac</subfield>
  </datafield>
  <datafield tag="900" ind1=" " ind2="7">
   <subfield code="a">Metadata rights reserved</subfield>
   <subfield code="b">CC BY-NC-4.0</subfield>
   <subfield code="u">http://creativecommons.org/licenses/by-nc/4.0</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="898" ind1=" " ind2=" ">
   <subfield code="a">BK010053</subfield>
   <subfield code="b">XK010053</subfield>
   <subfield code="c">XK010000</subfield>
  </datafield>
  <datafield tag="949" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="F">NATIONALLICENCE</subfield>
   <subfield code="b">NL-oxford</subfield>
  </datafield>
 </record>
</collection>
